Decision-making regarding anticoagulant therapy in the last phase of life: In-depth interview study with healthcare professionals (the OPTIMA trial)
Palliative Medicine · 2026
DOI: 10.1177/02692163251394875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Palliative Medicine, 2026. Verfasst von Marte A M van Hylckama Vlieg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Anticoagulants, Health Personnel, Decision Making, Terminal Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Erasmus Medisch Centrum.
Abstract (Originalsprache)
Background
Many patients in the last phase of life use anticoagulants. There is little evidence on the benefits and risks of (dis)continuation of anticoagulant therapy in this phase, leaving healthcare professionals with a complex clinical dilemma.
Aim
To gain an in-depth understanding of the experiences, perspectives, and preferences of healthcare professionals regarding decision-making about anticoagulant therapy in the last phase of life.
Design
Semi-structured in-depth interviews were conducted and analyzed using a thematic content analysis. Setting/participants: This study was performed in the Dutch Federation of Anticoagulation Clinics, two hospitals, two hospices, and two palliative home care groups in the Netherlands. Thirty-two healthcare professionals regularly involved in care for patients in the last phase of life were interviewed.
Results
Healthcare professionals experienced decision-making regarding anticoagulant therapy in the last phase of life as difficult and multifactorial, due to a lack of knowledge on the incidence of events after (dis)continuing therapy, the uncertain risk trade-off between events with major consequences, the variety of indications for therapy, the variety of comorbidities and patient characteristics, and prognostic uncertainty. As a result, healthcare professionals act defensively when considering discontinuation, due to concerns about being held accountable for potential thrombotic events. Uncertainty in decision-making results in reactive decision-making in response to triggers such as active bleeding, low performance score, recognition of the dying phase, and patient’s preference.
Conclusions
This study highlighted the complexity of decision-making regarding anticoagulant therapy in the last phase of life. This results, in practice, in reactive instead of proactive decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
- Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Quality and Patient Care, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
ORCID-Profile: Marte A M van Hylckama Vlieg, Eric C T Geijteman
Förderung
- Erasmus Medisch Centrum
Zitieren
APA
van Hylckama Vlieg, M. A. M., de Beukelaar, K. J. I., Spreeuw, R. H. L., Kruip, M. J. H. A., Kuy, P. H. M. V., Heide, A. V., van der Rijt, C. C. D., & Geijteman, E. C. T. (2026). Decision-making regarding anticoagulant therapy in the last phase of life: In-depth interview study with healthcare professionals (the OPTIMA trial). Palliative Medicine. https://doi.org/10.1177/02692163251394875
Vancouver
van Hylckama Vlieg MAM, de Beukelaar KJI, Spreeuw RHL, Kruip MJHA, Kuy PHMV, Heide AV, et al. Decision-making regarding anticoagulant therapy in the last phase of life: In-depth interview study with healthcare professionals (the OPTIMA trial). Palliative Medicine. 2026. doi:10.1177/02692163251394875
BibTeX
@article{vanHylckamaVlieg2026,
author = {van Hylckama Vlieg, Marte A M and de Beukelaar, Karlijn J I and Spreeuw, Romy H L and Kruip, Marieke J H A and Kuy, P Hugo M van der and Heide, Agnes van der and van der Rijt, Carin C D and Geijteman, Eric C T},
title = {Decision-making regarding anticoagulant therapy in the last phase of life: In-depth interview study with healthcare professionals (the OPTIMA trial)},
journal = {Palliative Medicine},
year = {2026},
doi = {10.1177/02692163251394875}
}
EUVIMED